Enalaprilat: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== Enalaprilat == | |||
[[File:Enalaprilat_structure.svg|thumb|right|Chemical structure of Enalaprilat]] | |||
'''Enalaprilat''' is an [[angiotensin-converting enzyme inhibitor]] (ACE inhibitor) used primarily in the treatment of [[hypertension]] and [[congestive heart failure]]. It is the active metabolite of the prodrug [[enalapril]]. Enalaprilat is administered intravenously, which makes it suitable for patients who cannot take oral medications. | |||
Enalaprilat is primarily | |||
== | == Pharmacology == | ||
Enalaprilat works by inhibiting the [[angiotensin-converting enzyme]], which is responsible for the conversion of [[angiotensin I]] to [[angiotensin II]]. Angiotensin II is a potent vasoconstrictor, and its inhibition leads to vasodilation, reduced blood pressure, and decreased workload on the heart. This mechanism is beneficial in managing conditions such as hypertension and heart failure. | |||
== | == Clinical Use == | ||
Enalaprilat | |||
Enalaprilat is used in situations where rapid blood pressure control is necessary, such as in [[hypertensive emergencies]]. It is also used in patients who are unable to take oral medications due to conditions like [[vomiting]] or [[gastrointestinal obstruction]]. | |||
=== Administration === | |||
Enalaprilat is administered intravenously, typically in a hospital setting. The dosage and frequency depend on the patient's condition and response to the medication. It is important to monitor blood pressure and renal function during treatment. | |||
== Side Effects == | |||
Common side effects of enalaprilat include [[hypotension]], [[dizziness]], and [[renal impairment]]. Less common but serious side effects can include [[angioedema]] and [[hyperkalemia]]. Patients with a history of angioedema related to previous ACE inhibitor use should not receive enalaprilat. | |||
== Contraindications == | |||
Enalaprilat is contraindicated in patients with a history of [[angioedema]] related to previous ACE inhibitor therapy, and in patients with [[bilateral renal artery stenosis]]. It should be used with caution in patients with impaired renal function. | |||
== Related Pages == | |||
* [[Enalapril]] | |||
* [[Angiotensin-converting enzyme inhibitor]] | |||
* [[Hypertension]] | |||
* [[Congestive heart failure]] | |||
[[Category:ACE inhibitors]] | [[Category:ACE inhibitors]] | ||
[[Category:Antihypertensive | [[Category:Antihypertensive agents]] | ||
Latest revision as of 11:06, 15 February 2025
Enalaprilat[edit]

Enalaprilat is an angiotensin-converting enzyme inhibitor (ACE inhibitor) used primarily in the treatment of hypertension and congestive heart failure. It is the active metabolite of the prodrug enalapril. Enalaprilat is administered intravenously, which makes it suitable for patients who cannot take oral medications.
Pharmacology[edit]
Enalaprilat works by inhibiting the angiotensin-converting enzyme, which is responsible for the conversion of angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor, and its inhibition leads to vasodilation, reduced blood pressure, and decreased workload on the heart. This mechanism is beneficial in managing conditions such as hypertension and heart failure.
Clinical Use[edit]
Enalaprilat is used in situations where rapid blood pressure control is necessary, such as in hypertensive emergencies. It is also used in patients who are unable to take oral medications due to conditions like vomiting or gastrointestinal obstruction.
Administration[edit]
Enalaprilat is administered intravenously, typically in a hospital setting. The dosage and frequency depend on the patient's condition and response to the medication. It is important to monitor blood pressure and renal function during treatment.
Side Effects[edit]
Common side effects of enalaprilat include hypotension, dizziness, and renal impairment. Less common but serious side effects can include angioedema and hyperkalemia. Patients with a history of angioedema related to previous ACE inhibitor use should not receive enalaprilat.
Contraindications[edit]
Enalaprilat is contraindicated in patients with a history of angioedema related to previous ACE inhibitor therapy, and in patients with bilateral renal artery stenosis. It should be used with caution in patients with impaired renal function.